Diamir Receives $1.5M NIH Grant to Advance microRNA Dx for Alzheimer's | GenomeWeb

NEW YORK (GenomeWeb) – Diamir today announced that it has received a two-year grant from the National Institutes of Health to further develop its microRNA-based diagnostic for Alzheimer's disease and its precursor, mild cognitive impairment (MCI).

Founded in 2009, Diamir's core technology involves the detection and analysis of miRNAs in plasma, and the company has thus far been focused on linking miRNA signatures with neurodegenerative conditions such as Alzheimer's and Parkinson's diseases.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.